KULÍŠKOVÁ, Petra, Lucie VAŠÁTKOVÁ and Iva SLANINOVÁ. Quaternary Benzophenanthridine Alkaloids Act as Smac Mimetics and Overcome Resistance to Apoptosis. International Journal of Molecular Sciences. BASEL: MDPI, 2023, vol. 24, No 20, p. 1-16. ISSN 1661-6596. Available from: https://dx.doi.org/10.3390/ijms242015405.
Other formats:   BibTeX LaTeX RIS
Basic information
Original name Quaternary Benzophenanthridine Alkaloids Act as Smac Mimetics and Overcome Resistance to Apoptosis
Authors KULÍŠKOVÁ, Petra (203 Czech Republic, belonging to the institution), Lucie VAŠÁTKOVÁ (203 Czech Republic, belonging to the institution) and Iva SLANINOVÁ (203 Czech Republic, belonging to the institution).
Edition International Journal of Molecular Sciences, BASEL, MDPI, 2023, 1661-6596.
Other information
Original language English
Type of outcome Article in a journal
Field of Study 10608 Biochemistry and molecular biology
Country of publisher Switzerland
Confidentiality degree is not subject to a state or trade secret
WWW URL
Impact factor Impact factor: 5.600 in 2022
RIV identification code RIV/00216224:14110/23:00132433
Organization unit Faculty of Medicine
Doi http://dx.doi.org/10.3390/ijms242015405
UT WoS 001090041300001
Keywords in English apoptosis; benzophenanthridine alkaloids; cancer; cell death; cIAP; Smac mimetic drug resistance; chelerythrine; sanguinarine
Tags 14110114, 14110513, rivok
Tags International impact, Reviewed
Changed by Changed by: Mgr. Tereza Miškechová, učo 341652. Changed: 13/2/2024 13:38.
Abstract
Defects in cell death signaling pathways are one of the hallmarks of cancer and can lead to resistance to conventional therapy. Natural products are promising compounds that can overcome this resistance. In the present study we studied the effect of six quaternary benzophenanthridine alkaloids (QBAs), sanguinarine, chelerythrine, sanguirubine, chelirubine, sanguilutine, and chelilutine, on Jurkat leukemia cells, WT, and cell death deficient lines derived from them, CASP3/7/6(-/-) and FADD(-/-), and on solid tumor, human malignant melanoma, A375 cells. We demonstrated the ability of QBAs to overcome the resistance of these deficient cells and identified a novel mechanism for their action. Sanguinarine and sanguirubine completely and chelerythrine, sanguilutine, and chelilutine partially overcame the resistance of CASP3/7/6(-/-) and FADD(-/-) cells. By detection of cPARP, a marker of apoptosis, and pMLKL, a marker of necroptosis, we proved the ability of QBAs to induce both these cell deaths (bimodal cell death) with apoptosis preceding necroptosis. We identified the new mechanism of the cell death induction by QBAs, the downregulation of the apoptosis inhibitors cIAP1 and cIAP2, i.e., an effect similar to that of Smac mimetics.
Links
MUNI/A/1098/2022, interní kód MUName: Nespecifická imunita u chorob imunitního systému
Investor: Masaryk University, Non-specific immunity in immune system diseases
MUNI/A/1393/2022, interní kód MUName: Biomedicínské vědy III
Investor: Masaryk University
PrintDisplayed: 20/7/2024 08:24